Horne Rob, Price David, Cleland Jen, Costa Rui, Covey Donna, Gruffydd-Jones Kevin, Haughney John, Henrichsen Svein Hoegh, Kaplan Alan, Langhammer Arnulf, Østrem Anders, Thomas Mike, van der Molen Thys, Virchow J Christian, Williams Siân
Centre for Behavioural Medicine, School of Pharmacy University of London, UK.
BMC Pulm Med. 2007 May 22;7:8. doi: 10.1186/1471-2466-7-8.
Clinical trials show that asthma can be controlled in the majority of patients, but poorly controlled asthma still imposes a considerable burden. The level of asthma control achieved reflects the behaviour of both healthcare professionals and patients. A key challenge for healthcare professionals is to help patients to engage in self-management behaviours with optimal adherence to appropriate treatment. These issues are particularly relevant in primary care, where most asthma is managed. An international panel of experts invited by the International Primary Care Respiratory Group considered the evidence and discussed the implications for primary care practice.
Causes of poor control: Clinical factors such as exposure to triggers and concomitant rhinitis are important but so are patient behavioural factors. Behaviours such as smoking and nonadherence may reduce the efficacy of treatment and patients' perceptions influence these behaviours. Perceptual barriers to adherence include doubting the need for treatment when symptoms are absent and concerns about potential adverse effects. Under-treatment may also be related to patients' underestimation of the significance of symptoms, and lack of awareness of achievable control.
Three key implications for healthcare professionals emerged from the debate. First, the need for simple tools to assess asthma control. Two approaches considered were the monitoring of biometric markers of control and questionnaires to record patient-reported outcomes. Second, to understand the reasons for poor control for individual patients, identifying both clinical (e.g. rhinitis) and behavioural factors (e.g. smoking and nonadherence to treatment). Third was the need to incorporate, within asthma review, an assessment of patient perspectives including their goals and aspirations and to elicit their beliefs and concerns about asthma and its treatment. This can be used as a basis for agreement between the healthcare professional and patient on a predefined target regarding asthma control and a treatment plan to achieve this.
Optimum review of asthma is essential to improve control. A key priority is the development of simple and effective tools for identifying poor control for individual patients coupled with a tailored approach to treatment to enable patients to set and achieve realistic goals for asthma control.
临床试验表明,大多数哮喘患者的病情可以得到控制,但控制不佳的哮喘仍然带来相当大的负担。所实现的哮喘控制水平反映了医护人员和患者双方的行为。医护人员面临的一项关键挑战是帮助患者进行自我管理行为,并最佳地坚持适当治疗。这些问题在大多数哮喘患者接受管理的初级保健中尤为重要。国际初级保健呼吸组邀请的一个国际专家小组审议了相关证据,并讨论了对初级保健实践的影响。
控制不佳的原因:接触诱发因素和并发鼻炎等临床因素很重要,但患者行为因素也同样重要。吸烟和不坚持治疗等行为可能会降低治疗效果,而患者的认知会影响这些行为。坚持治疗的认知障碍包括在无症状时怀疑治疗的必要性以及对潜在不良反应的担忧。治疗不足也可能与患者对症状重要性的低估以及对可实现控制的认识不足有关。
辩论产生了对医护人员的三项关键影响。第一,需要简单工具来评估哮喘控制情况。考虑的两种方法是监测控制的生物标志物和通过问卷记录患者报告的结果。第二,了解个体患者控制不佳的原因,识别临床因素(如鼻炎)和行为因素(如吸烟和不坚持治疗)。第三,在哮喘复查中需要纳入对患者观点的评估,包括他们的目标和期望,并了解他们对哮喘及其治疗的信念和担忧。这可作为医护人员与患者就哮喘控制的预定义目标及实现该目标的治疗计划达成一致的基础。
对哮喘进行最佳复查对于改善控制至关重要。一个关键优先事项是开发简单有效的工具来识别个体患者的控制不佳情况,并采用量身定制的治疗方法,使患者能够设定并实现哮喘控制的现实目标。